Pathogenesis, emerging therapeutic targets and treatment in sialidosis

Bibliography

• EBonten, Avan der Spoel, MFornerod, et al. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev 1996;10(24):3156-69
   PubMed Web of Science ®Google Scholar
• AVPshezhetsky, CRichard, LMichaud, et al. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet 1997;15(3):316-20
   Google Scholar
• PDurand, RGatti, SCavalieri, et al. Sialidosis (mucolipidosis I). Helv Paediatr Acta 1977;32(4-5):391-400
   PubMedGoogle Scholar
• MCantz, JGehler, JSpranger. Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts. Biochem Biophys Res Commun 1977;74(2):732-8
   Google Scholar
• JALowden, JSO’Brien. Sialidosis: a review of human neuraminidase deficiency. Am J Hum Genet 1979;31(1):1-18
   PubMed Web of Science ®Google Scholar
• GThomas. The online metabolic & molecular bases of inherited diseases. McGraw-Hill Publishing Co; New York: 2013
   Google Scholar
• Ad’Azzo, EBonten. Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease. Biochem Soc Trans 2010;38(6):1453-7
   Google Scholar
• ACaciotti, MDi Rocco, MFilocamo, et al. Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients. J Neurol 2009;256(11):1911-15
   Google Scholar
• YTakahashi, YNakamura, SYamaguchi, TOrii. Urinary oligosaccharide excretion and severity of galactosialidosis and sialidosis. Clin Chim Acta 1991;203(2-3):199-210
   Google Scholar
• LCanafoglia, ARobbiano, DPareyson, et al. Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus. Neurology 2014;82(22):2003-6
   PubMed Web of Science ®Google Scholar
• MMuona, SFBerkovic, LMDibbens, et al. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. Nat Genet 2014;47(1):39-46
   Google Scholar
• ISobral, LCachulo Mda, JFigueira, RSilva. Sialidosis type I: ophthalmological findings. BMJ Case Rep 2014;2014:1-17
   Google Scholar
• DJLoren, YCampos, Ad’Azzo, et al. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase. J Perinatol 2005;25(7):491-4
   Google Scholar
• BHLee, YMKim, JHKim, et al. Histological, biochemical, and genetic characterization of early-onset fulminating sialidosis type 2 in a Korean neonate with hydrops fetalis. Brain Dev 2014;36(2):171-5
   Google Scholar
• RRosenberg, EHalimi, KMention-Mulliez, et al. Five year follow-up of two sisters with type II sialidosis: systemic and ophthalmic findings including OCT analysis. J Pediatr Ophthalmol Strabismus 2013;50 Online:e33-6
   Google Scholar
• EJBonten, IAnnunziata, Ad’Azzo. Lysosomal multienzyme complex: pros and cons of working together. Cell Mol Life Sci 2014;71(11):2017-32
   PubMed Web of Science ®Google Scholar
• Ad’Azzo, GAndria, EBonten, IAnnunziata. The online metabolic & molecular bases of inherited diseases. McGraw-Hill Publishing Co; New York: 2013
   Google Scholar
• AVarki, RSchauer. Sialic acids. In: AVarki, RDCummings, JDEsko, HHFreeze, PStanley, CRBertozzi, et al. editors. Essentials of glycobiology. 2nd edition. Cold Spring; Harbor, NY: 2009
   Google Scholar
• EMonti, EBonten, AD’Azzo, et al. Sialidases in vertebrates: a family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem 2010;64:403-79
   PubMed Web of Science ®Google Scholar
• TMiyagi, KYamaguchi. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 2012;22(7):880-96
   PubMed Web of Science ®Google Scholar
• EGiacopuzzi, RBresciani, RSchauer, et al. New insights on the sialidase protein family revealed by a phylogenetic analysis in metazoa. PLoS One 2012;7(8):e44193
   Google Scholar
• VSmutova, AAlbohy, XPan, et al. Structural basis for substrate specificity of mammalian neuraminidases. PLoS One 2014;9(9):1-12
   Google Scholar
• EJBonten, YCampos, VZaitsev, et al. Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization. J Biol Chem 2009;284(41):28430-41
   PubMed Web of Science ®Google Scholar
• KELukong, VSeyrantepe, KLandry, et al. Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J Biol Chem 2001;276(49):46172-81
   Web of Science ®Google Scholar
• KELukong, MAElsliger, YChang, et al. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex. Hum Mol Genet 2000;9(7):1075-85
   PubMed Web of Science ®Google Scholar
• EJBonten, WFArts, MBeck, et al. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum Mol Genet 2000;9(18):2715-25
   PubMed Web of Science ®Google Scholar
• KItoh, YNaganawa, FMatsuzawa, et al. Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes. J Hum Genet 2002;47(1):29-37
   Google Scholar
• YJLee, SKSon, JHPark, et al. NEU1 mutation in a Korean infant with type 2 sialidosis presenting as isolated fetal ascites. Pediatr Neonatol 2015;56(1):68-9
   Google Scholar
• RPenzel, JUhl, JKopitz, et al. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient. FEBS Lett 2001;501(2-3):135-8
   Google Scholar
• PRanganath, VSharma, SDanda, et al. Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India. Indian J Med Res 2012;136(6):1048-50
   Google Scholar
• Nde Geest, EBonten, LMann, et al. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 2002;11(12):1455-64
   PubMed Web of Science ®Google Scholar
• EZanoteli, Dvan de Vlekkert, EJBonten, et al. Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue. Biochim Biophys Acta 2010;1802(7-8):659-72
   Google Scholar
• IAnnunziata, APatterson, DHelton, et al. Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-beta secretion via deregulated lysosomal exocytosis. Nat Commun 2013;4:2734
   Google Scholar
• EJBonten, GYogalingam, HHu, et al. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis. Biochim Biophys Acta 2013;1832(10):1784-92
   Google Scholar
• XYZhou, HMorreau, RRottier, et al. Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev 1995;9(21):2623-34
   PubMed Web of Science ®Google Scholar
• LHermo, NKorah, MGregory, et al. Structural alterations of epididymal epithelial cells in cathepsin A-deficient mice affect the blood-epididymal barrier and lead to altered sperm motility. J Androl 2007;28(5):784-97
   PubMedGoogle Scholar
• VSeyrantepe, AHinek, JPeng, et al. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 2008;117(15):1973-81
   PubMed Web of Science ®Google Scholar
• LDridi, VSeyrantepe, AFougerat, et al. Positive regulation of insulin signaling by neuraminidase 1. Diabetes 2013;62(7):2338-46
   Google Scholar
• GYogalingam, EJBonten, Dvan de Vlekkert, et al. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 2008;15(1):74-86
   Web of Science ®Google Scholar
• GMGriffiths, ATsun, JCStinchcombe. The immunological synapse: a focal point for endocytosis and exocytosis. J Cell Biol 2010;189(3):399-406
   PubMed Web of Science ®Google Scholar
• MASamie, HXu. Lysosomal exocytosis and lipid storage disorders. J Lipid Res 2014;55(6):995-1009
   PubMed Web of Science ®Google Scholar
• ARodriguez, PWebster, JOrtego, NWAndrews. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 1997;137(1):93-104
   PubMed Web of Science ®Google Scholar
• JKJaiswal, NWAndrews, SMSimon. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol 2002;159(4):625-35
   PubMed Web of Science ®Google Scholar
• JStinchcombe, GBossi, GMGriffiths. Linking albinism and immunity: the secrets of secretory lysosomes. Science 2004;305(5680):55-9
   PubMed Web of Science ®Google Scholar
• JPLuzio, YHackmann, NMDieckmann, GMGriffiths. The biogenesis of lysosomes and lysosome-related organelles. Cold Spring Harb Perspect Biol 2014;6(9):a016840
   PubMed Web of Science ®Google Scholar
• OJHolt, FGallo, GMGriffiths. Regulating secretory lysosomes. J Biochem 2006;140(1):7-12
   Google Scholar
• MSchwake, BSchroder, PSaftig. Lysosomal membrane proteins and their central role in physiology. Traffic 2013;14(7):739-48
   PubMed Web of Science ®Google Scholar
• PEKima, BBurleigh, NWAndrews. Surface-targeted lysosomal membrane glycoprotein-1 (Lamp-1) enhances lysosome exocytosis and cell invasion by Trypanosoma cruzi. Cell Microbiol 2000;2(6):477-86
   Google Scholar
• XWu, KASteigelman, EBonten, et al. Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. Biochim Biophys Acta 2010;1802(2):259-68
   Google Scholar
• Ad’Azzo, EHKolodny, EBonten, IAnnunziata. Storage disease of the reticuloendothelial system 7th edition. Nathan and Oski’s; New York: 2009
   Google Scholar
• CMBellettato, MScarpa. Pathophysiology of neuropathic lysosomal storage disorders. J Inherit Metab Dis 2010;33(4):347-62
   PubMed Web of Science ®Google Scholar
• ESidransky, GLopez. The link between the GBA gene and parkinsonism. Lancet Neurol 2012;11(11):986-98
   PubMed Web of Science ®Google Scholar
• SKeilani, YLun, ACStevens, et al. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-beta peptide. J Neurosci 2012;32(15):5223-36
   PubMed Web of Science ®Google Scholar
• CMartins, HHulkova, LDridi, et al. Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model. Brain 2015;138(Pt 2):336-55
   PubMedGoogle Scholar
• KOhmi, HZZhao, EFNeufeld. Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. PLoS One 2011;6(11):e27461
   PubMed Web of Science ®Google Scholar
• KOhmi, LCKudo, SRyazantsev, et al. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci USA 2009;106(20):8332-7
   Google Scholar
• VSeyrantepe, AIannello, FLiang, et al. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem 2010;285(1):206-15
   Google Scholar
• SOrtolano, IVieitez, CNavarro, CSpuch. Treatment of lysosomal storage diseases: recent patents and future strategies. Recent Pat Endocr Metab Immune Drug Discov 2014;8(1):9-25
   PubMedGoogle Scholar
• EJBonten, DWang, JNToy, et al. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis. FASEB J 2004;18(9):971-3
   Google Scholar
• DWang, EJBonten, GYogalingam, et al. Short-term, high dose enzyme replacement therapy in sialidosis mice. Mol Genet Metab 2005;85(3):181-9
   Google Scholar
• EJBonten, Ad’Azzo. Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein/cathepsin A. J Biol Chem 2000;275(48):37657-63
   Google Scholar
• HHu, EGomero, EBonten, et al. Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis. Mol Ther 2012;20(2):267-74
   PubMed Web of Science ®Google Scholar
• SPattison, MPankarican, CARupar, et al. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression. Hum Mutat 2004;23(1):32-9
   Google Scholar
• CSergi, RPenzel, JUhl, et al. Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene. Hum Genet 2001;109(4):421-8
   Google Scholar
• YZHuang, SCLai, CSLu, et al. Abnormal cortical excitability with preserved brainstem and spinal reflexes in sialidosis type I. Clin Neurophysiol 2008;119(5):1042-50
   Google Scholar
• VSeyrantepe, HPoupetova, RFroissart, et al. Molecular pathology of NEU1 gene in sialidosis. Hum Mutat 2003;22(5):343-52
   Google Scholar
• YSekijima, KNakamura, DKishida, et al. Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene. Intern Med 2013;52(1):119-24
   Google Scholar
• YNaganawa, KItoh, MShimmoto, et al. Molecular and structural studies of Japanese patients with sialidosis type 1. J Hum Genet 2000;45(4):241-9
   Google Scholar